NCT05598853
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05598853
Title Intrathecal Double Checkpoint Inhibition (IT-IO)
Acronym IT-IO
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors University of Zurich
Indications
Therapies
Age Groups: adult | senior
Covered Countries CHE

Facility Status City State Zip Country Details
University Hospital Zurich Zurich Canton of Zurich Switzerland Details
University Hospital Basel Basel Switzerland Details
University Hospital Geneva Geneva Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field